Inhibrx Biosciences, Inc.

INBX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$153,088$186,567$216,520$152,596
Short-Term Investments$0$0$0$0
Receivables$837$967$214$420
Inventory$0$0$0$0
Other Curr. Assets$7,498$6,430$6,652$7,382
Total Curr. Assets$161,423$193,964$223,386$160,398
Property Plant & Equip (Net)$10,310$11,345$12,450$13,538
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$5,738$6,809$6,803$6,831
Total NC Assets$16,048$18,154$19,253$20,369
Other Assets$0$0$0$0
Total Assets$177,471$212,118$242,639$180,767
Liabilities
Payables$6,773$8,292$8,892$9,245
Short-Term Debt$2,247$2,169$1,973$1,595
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$26,963$28,478$32,774$29,890
Total Curr. Liab.$35,983$38,939$43,639$40,730
LT Debt$4,741$104,620$104,557$6,453
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$99,917$0$0$0
Total NC Liab.$104,658$104,620$104,557$6,453
Other Liabilities$0$0$0$0
Cap. Leases$0$7,510$7,877$6,453
Total Liabilities$140,641$143,559$148,196$47,183
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings-$213,353-$178,097-$149,443-$106,132
AOCI$0$0$0$0
Other Equity$250,182$246,655$243,885$239,715
Total Equity$36,830$68,559$94,443$133,584
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$177,471$212,118$242,639$180,767
Net Debt-$146,100-$79,778-$109,990-$144,548
Inhibrx Biosciences, Inc. (INBX) Financial Statements & Key Stats | AlphaPilot